Divide and Conquer

About:

Divide & Conquer is a biotechnology company focused on discovery and development of a new class of oncology therapeutics

Website: https://www.conquer.bio/

Twitter/X: conquerbio

Top Investors: Medicxi

Description:

Divide & Conquer is a biotechnology company based in Cambridge, UK and working in collaboration with the University of Heidelberg and German Cancer Research Center (DKFZ). The company is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumours with very poor life expectancy. Divide & Conquer is funded by VC firm Medicxi.

Total Funding Amount:

10M GBP

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)conquer.bio

Founders:

David Grainger

Number of Employees:

1-10

Last Funding Date:

2019-09-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai